Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adenovirus-triggered innate signalling pathways
György Fejér, Marina A. Freudenberg, Urs F. Greber, et al.
European Journal of Microbiology and Immunology (2011) Vol. 1, Iss. 4, pp. 279-288
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic
Samir Andrade Mendonça, Réka Lőrincz, Paul J. Rice-Boucher, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 252
Pre-existing immunity against Ad vectors
Hugues Fausther‐Bovendo, Gary Wong
Human Vaccines & Immunotherapeutics (2014) Vol. 10, Iss. 10, pp. 2875-2884
Open Access | Times Cited: 239
Innate Immunity to Adenovirus
Rodinde Hendrickx, Nicole Stichling, Jorien Anne Koelen, et al.
Human Gene Therapy (2014) Vol. 25, Iss. 4, pp. 265-284
Open Access | Times Cited: 196
Principles of Virus Uncoating: Cues and the Snooker Ball
Yohei Yamauchi, Urs F. Greber
Traffic (2016) Vol. 17, Iss. 6, pp. 569-592
Open Access | Times Cited: 119
Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
Lynda Coughlan
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 118
Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions
Robert Root‐Bernstein
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 2108-2108
Open Access | Times Cited: 98
Approved and marketed nanoparticles for disease targeting and applications in COVID-19
Ahmed A. H. Abdellatif, Abdullah Fahad Alsowinea
Nanotechnology Reviews (2021) Vol. 10, Iss. 1, pp. 1941-1977
Open Access | Times Cited: 74
Adenovirus signalling in entry
Nina Wolfrum, Urs F. Greber
Cellular Microbiology (2012) Vol. 15, Iss. 1, pp. 53-62
Closed Access | Times Cited: 84
Human antimicrobial peptides in ocular surface defense
Imran Mohammed, Dalia G. Said, Harminder S. Dua
Progress in Retinal and Eye Research (2017) Vol. 61, pp. 1-22
Closed Access | Times Cited: 84
Key Role of the Scavenger Receptor MARCO in Mediating Adenovirus Infection and Subsequent Innate Responses of Macrophages
Mareike D. Maler, Peter Nielsen, Nicole Stichling, et al.
mBio (2017) Vol. 8, Iss. 4
Open Access | Times Cited: 74
Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines
Ekramy E. Sayedahmed, Ahmed Elkashif, Marwa Alhashimi, et al.
Vaccines (2020) Vol. 8, Iss. 4, pp. 574-574
Open Access | Times Cited: 60
Strategies for Vaccination: Conventional Vaccine Approaches Versus New-Generation Strategies in Combination with Adjuvants
Abdellatif Bouazzaoui, Ahmed A. H. Abdellatif, Faisal A. Al-Allaf, et al.
Pharmaceutics (2021) Vol. 13, Iss. 2, pp. 140-140
Open Access | Times Cited: 48
From Co-Infections to Autoimmune Disease via Hyperactivated Innate Immunity: COVID-19 Autoimmune Coagulopathies, Autoimmune Myocarditis and Multisystem Inflammatory Syndrome in Children
Robert Root‐Bernstein
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 3001-3001
Open Access | Times Cited: 22
Innate Immune Response to Viral Vectors in Gene Therapy
Yixuan Wang, Wenwei Shao
Viruses (2023) Vol. 15, Iss. 9, pp. 1801-1801
Open Access | Times Cited: 17
STAT2 Knockout Syrian Hamsters Support Enhanced Replication and Pathogenicity of Human Adenovirus, Revealing an Important Role of Type I Interferon Response in Viral Control
Károly Tóth, Sang Ryeul Lee, Baoling Ying, et al.
PLoS Pathogens (2015) Vol. 11, Iss. 8, pp. e1005084-e1005084
Open Access | Times Cited: 54
Concepts in Light Microscopy of Viruses
Robert Witte, Vardan Andriasyan, Fanny Georgi, et al.
Viruses (2018) Vol. 10, Iss. 4, pp. 202-202
Open Access | Times Cited: 51
Transient pacing in pigs with complete heart block via myocardial injection of mRNA coding for the T-box transcription factor 18
David Wolfson, Nam Kyun Kim, Ki Hong Lee, et al.
Nature Biomedical Engineering (2024) Vol. 8, Iss. 9, pp. 1124-1141
Open Access | Times Cited: 5
Harnessing nc886 to overcome immune and apoptotic barriers in adenoviral gene therapy
Mohamed Hammad, Hossam M. Ashour
Molecular Therapy — Nucleic Acids (2025) Vol. 36, Iss. 2, pp. 102493-102493
Closed Access
MEK/ERK signaling pathway is required for enterovirus 71 replication in immature dendritic cells
Weifeng Shi, Xueling Hou, Hongjun Peng, et al.
Virology Journal (2014) Vol. 11, Iss. 1
Open Access | Times Cited: 29
The importance of coagulation factors binding to adenovirus: historical perspectives and implications for gene delivery
Estrella López-Gordo, Laura Denby, Stuart A. Nicklin, et al.
Expert Opinion on Drug Delivery (2014) Vol. 11, Iss. 11, pp. 1795-1813
Closed Access | Times Cited: 22
Disparate Entry of Adenoviruses Dictates Differential Innate Immune Responses on the Ocular Surface
Matthew R. Pennington, Amrita Saha, David F. Painter, et al.
Microorganisms (2019) Vol. 7, Iss. 9, pp. 351-351
Open Access | Times Cited: 21
Biology of Adenovirus Cell Entry
Stefania Luisoni, Urs F. Greber
Elsevier eBooks (2016), pp. 27-58
Closed Access | Times Cited: 17
Transcriptomic and proteomic analyses reveal new insights into the regulation of immune pathways during adenovirus type 2 infection
Hongxing Zhao, Maoshan Chen, Alberto Valdés, et al.
BMC Microbiology (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 10
Oncolytic Adenovirus ORCA-010 Activates Proinflammatory Myeloid Cells and Facilitates T Cell Recruitment and Activation by PD-1 Blockade in Melanoma
Ioanna Milenova, Marta López González, Dafne C.A. Quixabeira, et al.
Human Gene Therapy (2021) Vol. 32, Iss. 3-4, pp. 178-191
Closed Access | Times Cited: 9
Xenogenic Adenoviral Vectors
Suresh K. Mittal, Yadvinder S. Ahi, Sai Vikram Vemula
Elsevier eBooks (2016), pp. 495-528
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top